Skip to content

Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study

A Comparison of Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04179747
Enrollment
28
Registered
2019-11-27
Start date
2018-01-18
Completion date
2018-07-24
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Keywords

Sexual Dysfunctions, Men Health

Brief summary

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with two arms involving a control group. The study was conducted with an aim of pilot and feasibility study to evaluate the efficacy and suitability of cognitive behavior psychotherapy with individuals suffering from erectile dysfunction.

Interventions

The Cognitive Behavior Psychotherapy was provided for a period of maximum 3 months.

The participants in control group arm received Sildenafil Citrate 50mg tablet on demand for a period of maximum 3 months.

Sponsors

International Islamic University, Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. Men diagnosed with erectile dysfunction 2. Must be in the age range of 18 to 39 years 3. Must be in a stable heterosexual relationship 4. Must not be suffering from any medical or psychiatric illness

Exclusion criteria

1. Men not meeting criteria of diagnosis of erectile dysfunction 2. Men not in a heterosexual relationship 3. Men of or above the age of 40 years 4. Men diagnosed with any medical or psychiatric illness or obese men

Design outcomes

Primary

MeasureTime frameDescription
International Index of Erectile Functioning-53 months maximumThe minimum scale score is 5. The maximum scale score is 25. The higher score indicates better erectile functioning.

Secondary

MeasureTime frameDescription
Depression, Anxiety, and Stress Scale-213 months maximumThe scale has three sub-scales. 1. Depression sub scale, Minimum Score: Zero; Maximum Score: 42 2. Anxiety sub scale, Minimum Score: Zero; Maximum Score: 42 3. Stress sub scale, Minimum Score: Zero; Maximum Score: 42 The lowest scores on each of the sub scales indicate better functioning, the higher scores on each sub scale indicate a worse outcome.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026